Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3041200 | 0.78 | NCEH1 (0.41) | KDM4EHPGDL3MBTL1NCEH1GAA | |
| SCHEMBL6627314 | 0.75 | NPC1 (0.48) | HPGDL3MBTL1 | |
| SCHEMBL5963023 | 0.71 | ALDH1A1 (0.46) | TDP1KDM4EHPGD | |
| SCHEMBL10345808 | 0.70 | ALOX5 (0.51) | TDP1KDM4EL3MBTL1GAA | |
| SCHEMBL9770378 | 0.70 | GPR55 (0.44) | — | |
| SCHEMBL11495787 | 0.70 | ALDH1A1 (0.46) | TDP1L3MBTL1NCEH1 | |
| SCHEMBL9770383 | 0.70 | GPR55 (0.44) | — | |
| SCHEMBL9514367 | 0.68 | GAA (0.44) | GAA | |
| SCHEMBL340868 | 0.66 | GPR55 (0.46) | — | |
| SCHEMBL30874096 | 0.66 | MAPT (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8647878-B2 | Highly refractive immersion liquids and their use | CARL ZEISS AG (DE) | 2014-02-11 | — | — | US | disclosed |
| US-20100212547-A1 | Highly Refractive Immersion Liquids And Their Use | CARL ZEISS AG (DE) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100212547-A1 | Highly Refractive Immersion Liquids And Their Use | NR4A3, NR2E3, NR4A1 | TDP1 4272/4885KDM4E 3365/4885HPGD 3875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.